First of all, take all the weeks of merger negotiations and throw them out the window: It’s looking more and more like the only way the Democrats can pass health care reform — and they must pass health care reform — in the wake of yesterday’s election in More…
Among the chief discrepancies between the House and Senate health reform proposals is a provision of the House bill that would allow states to negotiate directly with pharmaceutical companies for lower drug prices on behalf of their lowest income seniors — those eligible for both Medicare and Medicaid. House leaders, More…
Via The Wall Street Journal, here’s the inane argument being tried by Merck, the pharmaceutical giant that defended itself before the Supreme Court this week against investors suing over the company’s failure to concede the risks of Vioxx before 2004, when the popular arthritis drug was More…
rss